![](/img/cover-not-exists.png)
Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?
Miller, C.R., Chappell, N.P., Leath, C.A., Phippen, N.T., Havrilesky, L.J., Barnett, J.C.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.427
Date:
April, 2015
File:
PDF, 55 KB
english, 2015